Different Medical Research From Middle East
View Published Articles →01About This Special Issue
The medical researches have a great revolution over the last decades. The development of hundreds of subspecialist and their underlying sub-subspecialties lead to uncountable articles in different fields of medicine. Regional variation of the authors has been neglected in this type of publications. The middle east is a unique area of this world. It has different pattern of illness, epidemiology, and presentation of different disease. The social background of middle east made the approach to the illness and research is different among the researchers in the medical field. The presentation of medical researches of different medical specialties including general Medicine, gastroenterology, hepatology, and diabetes will help to focus on the medical problems in our middle eastern and Arabic communities. It will also include researches from liver transplantation field too. It is highly specialized field need to be in separate entity, though the ethical and regional background of our communities made it different from the same specialties in western countries.Aims and Scope:
1. Evaluate the ability of different researches from different subspecialties to reflect the disease pattern difference in Middle East.
2. Present the different medical capacity of this medical group to share same scope towards their communities.
3. It will highlight the areas of strength, weakness in our researches, and its reflection to the community demands.
02Meet the Guest Editors
Our distinguished editors bring deep subject-matter expertise to curate high-quality research and ensure a rigorous peer-review process.
Lead Guest Editor
ABEER IBRAHIM
Alexandria University Faculty of Medicine, Internal Medicine Department, Alexandria, Egypt
Guest Editor
Yasmine Altawijri
King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Guest Editor
Urlike Laudon
King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Guest Editor
Hussein Elseisi
King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Guest Editor
Ali Albenmousa
Gastroenterology and Hepatology Department, Prince Sultan Medical City, Riyadh, Saudi Arabia
Guest Editor
Abdulrhman Alrobayan
Gastroenterology and Hepatology Department, Prince Sultan Medical City, Riyadh, Saudi Arabia
Guest Editor
Nasser Almasrri
Gastroenterology and Hepatology Department, Prince Sultan Medical City, Riyadh, Saudi Arabia
Guest Editor
Amani Elbanna
Internal Medicine department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
Guest Editor
Hoda Elaggan
Internal Medicine Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
Guest Editor
Azza Ismael
Internal Medicine Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
Guest Editor
Rania Abdelreheem
Internal Medicine Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
Guest Editor
Abeer Ibrahim
Internal Medicine department, Faculty of Medicine, Alexandria University, Alexandria, Egypt
03Published Articles
The following articles have been published in this special issue.
-
Issue: Volume 4, Issue 2-1, March 2016Pages: 18-23Received: 26 January 2016Accepted: 27 January 2016Published: 29 February 2016DOI: 10.11648/j.ajim.s.2016040201.14Downloads:Views:Abstract: Introduction: Lupus nephritis (LN) is common and carries a high burden of morbidity in SLE patients. The adipokine ‘‘visfatin’’is highly expressed in visceral fat, exerts several pro inflammatory functions and was demonstrated as a marker of endothelial dysfunction (ED) in chronic kidney disease (CKD). Aim of the work: to evaluate the state of seru... Show More -
Serum Chemerin Level: Does It Have a Role in Progression of Diabetic Nephropathy
Issue: Volume 4, Issue 2-1, March 2016Pages: 13-17Received: 24 October 2015Accepted: 26 October 2015Published: 30 November 2015DOI: 10.11648/j.ajim.s.2016040201.13Downloads:Views:Abstract: Background: Diabetic nephropathy has become the leading cause of end-stage renal failure in Europe, the United States and Japan (25-44%). Chemerin is a chemoattractant expressed in white adipose, liver and lung tissues. Chemerin is shown to be associated with inflammation which is involved in the pathogenesis of diabetic nephropathy. The aim of the... Show More -
Study of Serum Osteoprotegerin Level in Uremic Patients and Its Relation to Renal Bone Disease
Issue: Volume 4, Issue 2-1, March 2016Pages: 5-12Received: 11 September 2015Accepted: 13 September 2015Published: 25 October 2015DOI: 10.11648/j.ajim.s.2016040201.12Downloads:Views:Abstract: Introduction: Bone disease associated with renal failure is termed renal osteodystrophy and is quite heterogeneous. Microscopic examination of a bone biopsy specimen is still considered the gold standard for diagnosis. Nevertheless, recent studies suggest that serum markers of bone formation and resorption may be of additional help in assessing bon... Show More -
Issue: Volume 4, Issue 2-1, March 2016Pages: 1-4Received: 24 August 2015Accepted: 25 August 2015Published: 25 October 2015DOI: 10.11648/j.ajim.s.2016040201.11Downloads:Views:Abstract: Objective:Insulin resistance and progressive pancreatic β-cell failure are key factors in the development of type 2 diabetes.The aim of the present study was to define the relationship between Neutrophil Lymphocyte Ratio (NLR) and the degree of insulin resistance and β cell dysfunction in Type 2Diabetus Mellitus.Methods: This study was carried out ... Show More
